Susan Faye Dent, MD Susan Faye Dent, MD

Susan Faye Dent, MD

Medical Oncologist

No ratings available.
question Circle Img
Duke Health Provider question Circle Img
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-668-0718 Office number
919-613-4077
Fax number
919-668-6608 Appointments 919-668-0718 Office
919-613-4077 Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
919-668-6608 Appointments
919-668-0718 Office
919-613-4077 Fax number
WHERE I PROVIDE CARE
Profile
ABOUT ME

I am a medical oncologist and professor of medicine at Duke University. I am the associate director of breast cancer clinical research and co-director of the cardio-oncology Program at Duke University. My interest in the toxicities of cancer treatments, in particular, cardiotoxicity, led to the 2008 establishment of the first cardio-oncology clinic in Ottawa, Canada. I subsequently established the not-for-profit Canadian Cardiac Oncology Network (CCON) in 2011, an organization dedicated to learning how to deliver optimal cancer therapy without compromising cardiovascular health. In 2015, I launched the Global Cardio-Oncology Summit (GCOS), an annual meeting designed to bring health care providers from around the world together to learn about the potential cardiovascular impact of cancer therapies. As a faculty member at Duke University, I plan to use my expertise to promote breast cancer clinical research in order to provide the best care for cancer patients and foster the growth and development of a cardio-oncology program.

LANGUAGES I SPEAK
English
Training
EDUCATION
MD, McMaster University (Canada), 1990
RESIDENCY
Internal Medicine, University of Ottawa (Canada), 1990-1993
Medical Oncology, University of Ottawa (Canada), 1993-1995
FELLOWSHIP
Research Fellowship, National Cancer Centre of Canada, 1995-1996
Clinical Focus and Research
MY RESEARCH INTERESTS

My research over the last 20 years has focused on novel and emerging therapies for breast cancer as well as treatment-related toxicities including cardiotoxicity. I have led, as the principal investigator for Canada, a global phase III breast cancer trial, and I have been actively involved in steering committees at the International level. I have been a co-investigator of a number of investigator-initiated peer-reviewed funded studies and have been an active member of grant review boards including the Canadian Institute for Health Research (CIHR) and the Canadian Breast Cancer Foundation (CBCF). At the national level, I served for several years as a member of the clinical guidance panel for breast cancer for the Pan Canadian Drug Review. At Duke Health, my research will focus on identifying patients who are at risk of experiencing cancer therapy-related to cardiac dysfunction as well as optimizing cardiac health in order to provide optimal cancer therapy.
Industry Relationships and Collaborations
This faculty member has no reported relationships with industry.